Oral Therapeutic Education in Stimulated Parkinsonian Patients — BUCCO-PARK  

Parkinson Disease Clinical Trial

Official title: Exploratory Study of Oral Therapeutic Education in Stimulated Parkinsonian Patients: Monitoring of Periodontal Status and Microbiota

Status Recruiting

Clinical Trial Summary

The effect of periodontal disease on the general condition of patients remains today underestimated in Parkinson's disease. The BUCCO-PARK project aims to carry out an exploratory study of oral therapeutic education on the clinical evolution and fate of the microbiota of patients undergoing brain stimulation surgery. During the study, patients will follow the standard care pathway alone or combined with an oral therapeutic education. Biological samples will assess how the microbiota of these patients will be impacted. BUCCO-PARK aims to optimize the care of Parkinson's patients by integrating oral care.

Clinical Trial Description

Patients included will be randomized in one of both defined groups : experimental group, in which patients will receive an oral education or control group, in which patient only follow the traditional care pathway. Patients will be included in the trial before surgery after medical examination and life quality and oral environment evaluations. Oral therapeutic education for patients randomized in experimental group will be performed at inclusion, and 6, and 12 months after surgery. For all patients, an oral examination, an assessment of the quality of life and oral, fecal and blood samples will be carried out at inclusion, and 6 and 12 months after surgery. ;

Related Conditions & MeSH terms

• Oral Infection
• Parkinson Disease

• NCT number: NCT03965390
• Study type: Interventional
• Source: Rennes University Hospital
• Contact: Marie-Laure Gervais
• Phone: 0299284312
• Email: marie-laure.gervais@chu-rennes.fr
• Status: Recruiting
• Phase: N/A
• Start date: December 14, 2019
• Completion date: January 2028